Eterna Therapeutics Teams with Lineage Cell on Transplant Therapies

By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) is partnering with Lineage Cell Therapeutics, Inc. to develop stem cell lines for central nervous system diseases, the company said. Eterna’s mRNA gene-editing approach and Lineage’s expertise in gene editing aim to...